Search

Your search keyword '"Rubino, M"' showing total 1,146 results

Search Constraints

Start Over You searched for: Author "Rubino, M" Remove constraint Author: "Rubino, M"
1,146 results on '"Rubino, M"'

Search Results

1. Nuclear Physics Mid Term Plan at LNGS

2. Detectability of large-scale counter-rotating stellar disks in galaxies with integral-field spectroscopy

3. Peptide receptor radionuclide therapy with 177Lu- or 90Y-SSTR peptides in malignant pheochromocytomas (PCCs) and paragangliomas (PGLs): results from a single institutional retrospective analysis

7. Southern Ocean carbon sink enhanced by sea-ice feedbacks at the Antarctic Cold Reversal

8. Effect of Migalastat on cArdiac Involvement in FabRry Disease: MAIORA study

9. Erratum: Gas transport in firn: Multiple-tracer characterisation and model intercomparison for NEEM, Northern Greenland (Atmospheric Chemistry and Physics (2012) 12 (4259-4277))

10. Corrigendum to ``Gas transport in firn: multiple-tracer characterisation and model intercomparison for NEEM, Northern Greenland'' published in Atmos. Chem. Phys., 12, 4259–-4277, 2012

11. The SGLT2I Dapagliflozin reverses metabolic stress driving myocardial inflammation in a mouse model of heart failure with preserved ejection fraction: insights from single-cell RNA sequencing

13. Gastroenteropancreatic grade 3 neuroendocrine tumors: a single entity or a heterogeneous group? A retrospective analysis

14. Metronomic chemotherapy in patients with advanced neuroendocrine tumors: A single-center retrospective analysis

15. C63 PREVALENCE AND CLINICAL SIGNIFICANCE OF RIGHT VENTRICULAR PULMONARY ARTERIAL UNCOUPLING IN CARDIAC AMYLOIDOSIS

17. COVID-19 in patients with neuroendocrine neoplasms: two-year results of the INTENSIVE study

18. Multimodal treatment for resectable neuroendocrine carcinoma of the cervix

19. Effect of Migalastat on cArdiac Involvement in FabRry Disease: MAIORA study

21. Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: data from the Campania Rare Disease Registry

22. Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry

23. HCM-AF South Italy score for prediction of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy: data from a derivation and validation italian cohorts

26. Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry

27. Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry

28. Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry

29. Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study

30. A retrospective analysis of the correlation between functional imaging and clinical outcomes in grade 3 neuroendocrine tumors (Nets g3)

31. Should temozolomide be used on the basis of O6-methylguanine DNA methyltransferase status in patients with advanced neuroendocrine tumors? A systematic review and meta-analysis

35. The GALA project: Practical recommendations for the use of migalastat in clinical practice on the basis of a structured survey among Italian experts

37. COVID-19 outbreak in Lombardy: Impact on reducing solid cancer diagnoses in 2020

39. Corrigendum to ‘Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study’ [European Journal of Cancer 154 (2021) 246-252] (European Journal of Cancer (2021) 154(246-252) (S0959804921004044), (10.1016/j.ejca.2021.06.029))

40. Antibiotic use and associated factors in a large sample of hospitalised older people

42. Diagnostic and prognostic implications of myocardial work in cardiac amyloidosis and in genetic and non-genetic cardiomyopathies with hypertrophic phenotype

43. Pathophysiological, haemodynamic and prognostic implications of left atrial dysfunction in cardiac amyloidosis and other cardiomyopathies with hypertrophic phenotype

44. Diagnostic and prognostic implications of right ventricular-arterial coupling in cardiac amyloidosis and in genetic and non-genetic cardiomyopathies with hypertrophic phenotype

45. Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register

46. Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients

47. Mortality rate and risk factors for gastrointestinal bleeding in elderly patients

48. Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids

49. Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register

50. The GALA project: Practical recommendations for the use of migalastat in clinical practice on the basis of a structured survey among Italian experts

Catalog

Books, media, physical & digital resources